Strabismus Syndrome or Congenital Fibrosis of Extraocular Muscles (Ocular Motility Disorder) Panel
Use
This test is designed for individuals with clinical or suspected diagnosis of a strabismus syndrome and those exhibiting features indicative of congenital fibrosis of extraocular muscles (CFEOM) or Duane retraction syndrome (DRS).
Special Instructions
The test provides options for Exome-Wide CNV Analysis and STAT Testing, which accelerates the standard processing time. Options should be considered based on clinical need and time sensitivity of test results.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration. It is developed and validated following CAP and CLIA regulations. Testing must be ordered by a qualified Healthcare Provider and clinical information must be included for variant interpretation.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided